 EDEN PRAIRIE, Minn., Sept. 7, 2021 PRNewswire -- NeuroOne Medical Technologies Corporation Nasdaq: NMTC NeuroOne or the Company, a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it has received U.S. Food and Drug Administration FDA 510k clearance to market its Evo sEEG Electrode technology for temporary less than 24 hours use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain. 